N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.226 NOK 2.68% Market Closed
Market Cap: 726.9m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Cash Flow Statement

Cash Flow Statement
Nykode Therapeutics ASA

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(3)
(5)
(6)
(7)
(6)
(9)
(9)
(10)
(14)
(14)
(19)
(24)
181
176
175
172
(11)
(11)
(15)
(23)
(51)
(54)
(54)
(47)
(44)
(49)
(48)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
2
2
2
2
2
2
2
Other Non-Cash Items
0
(0)
(0)
(0)
0
(0)
(0)
(0)
3
1
4
6
10
14
9
7
19
14
16
21
4
2
(7)
(12)
(25)
(17)
(11)
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
(0)
0
(0)
0
1
(0)
0
3
0
1
(11)
(12)
(10)
(5)
(8)
14
12
12
25
(1)
3
(3)
(29)
(27)
(31)
Cash from Operating Activities
(3)
N/A
(5)
-72%
(6)
-19%
(6)
-8%
(6)
-1%
(8)
-32%
(9)
-7%
(10)
-13%
(10)
-3%
(10)
+3%
(13)
-32%
(16)
-19%
180
N/A
178
-1%
174
-2%
174
+0%
1
-99%
17
+1 375%
14
-18%
11
-22%
(21)
N/A
(52)
-149%
(55)
-7%
(61)
-10%
(97)
-59%
(91)
+6%
(87)
+4%
Investing Cash Flow
Capital Expenditures
(0)
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(3)
(3)
(3)
(2)
(1)
(2)
(2)
(1)
(1)
Other Items
0
0
0
0
0
0
0
0
(9)
(8)
(4)
(1)
(6)
(6)
(7)
(6)
12
11
9
14
14
14
17
8
9
9
7
Cash from Investing Activities
0
N/A
0
+45%
0
+3%
0
-6%
0
-32%
0
+38%
0
-14%
0
+39%
(9)
N/A
(9)
+5%
(4)
+56%
(1)
+69%
(6)
-425%
(6)
+0%
(7)
-18%
(6)
+15%
11
N/A
9
-20%
6
-33%
11
+90%
11
+1%
12
+8%
15
+28%
5
-65%
7
+31%
8
+11%
6
-22%
Financing Cash Flow
Net Issuance of Common Stock
21
1
1
0
0
26
25
25
26
1
1
2
0
(0)
0
(0)
21
21
21
21
2
2
2
2
46
45
45
Net Issuance of Debt
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
0
(1)
(1)
(1)
Other
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Cash from Financing Activities
21
N/A
1
-97%
1
+28%
0
-78%
0
-84%
26
+109 530%
25
0%
25
-1%
26
+3%
1
-96%
1
+4%
2
+41%
(0)
N/A
(1)
-158%
(0)
+52%
(0)
-24%
20
N/A
20
-1%
20
-1%
18
-8%
0
-98%
1
+117%
0
-42%
2
+281%
45
+2 492%
44
-2%
44
0%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
(2)
(1)
(0)
(0)
1
0
0
0
(1)
(1)
(1)
(1)
(0)
1
1
0
1
Net Change in Cash
18
N/A
(4)
N/A
(5)
-18%
(6)
-20%
(6)
-4%
17
N/A
17
-4%
15
-8%
6
-58%
(18)
N/A
(18)
-1%
(16)
+8%
174
N/A
171
-2%
168
-2%
168
0%
32
-81%
46
+42%
39
-15%
39
+1%
(10)
N/A
(40)
-301%
(40)
0%
(53)
-33%
(44)
+17%
(39)
+11%
(37)
+5%
Free Cash Flow
Free Cash Flow
(3)
N/A
(5)
-72%
(6)
-19%
(6)
-8%
(6)
-1%
(8)
-32%
(9)
-8%
(10)
-13%
(11)
-3%
(10)
+3%
(13)
-31%
(16)
-19%
180
N/A
178
-1%
174
-2%
174
+0%
0
-100%
15
+5 039%
11
-24%
8
-27%
(23)
N/A
(53)
-128%
(57)
-7%
(63)
-11%
(99)
-57%
(92)
+7%
(88)
+4%

See Also

Discover More